Active Substance & Generic Molecule Directory

Sodium Chloride 0. in Malaysia: Registered Brands, Dosages & Price Comparison

Directory of all approved pharmaceutical brands containing Sodium Chloride 0. registered with the National Pharmaceutical Regulatory Agency (NPRA) / Ministry of Health Malaysia (KKM).

9
Registered Brands
Availability in Malaysia:9 Prescription (MAL-A)
Showing 9 of 9 registered brands
MAL Reg NoBrand Formulation NameStrength / DosageClassificationRegistration HolderAction
MAL19920222AZB. BRAUN 0.18% SODIUM CHLORIDE & 4% GLUCOSE IV INFUSION B.P. (500ML)44MG/MLPrescription (MAL-A)B. BRAUN MEDICAL INDUSTRIES SDN. BHD.Compare →
MAL20000205AZB. BRAUN 0.33% SODIUM CHLORIDE & 5% GLUCOSE IV INFUSION BP (500ML)55MG/MLPrescription (MAL-A)B. BRAUN MEDICAL INDUSTRIES SDN. BHD.Compare →
MAL19910413AZB. BRAUN 0.45% SODIUM CHLORIDE & 5% GLUCOSE IV INFUSION BP4.5MG/MLPrescription (MAL-A)B. BRAUN MEDICAL INDUSTRIES SDN. BHD.Compare →
MAL19910434AZB. BRAUN 0.9% SODIUM CHLORIDE & 5% GLUCOSE IV INFUSION BP9MG/MLPrescription (MAL-A)B. BRAUN MEDICAL INDUSTRIES SDN. BHD.Compare →
MAL20001035AZB. BRAUN 0.9% SODIUM CHLORIDE INJ BP (10ML)0.9GPrescription (MAL-A)B. BRAUN MEDICAL INDUSTRIES SDN. BHD.Compare →
MAL08082440ASZB. Braun 0.9% Sodium Chloride IV Infusion BP9.000 g 1000 mlPrescription (MAL-A)B. BRAUN MEDICAL INDUSTRIES SDN. BHD.Compare →
MAL19920235AEZB. Braun 5% Dextrose in 0.3% Sodium Chloride for Intravenous Infusion3.3MG/MLPrescription (MAL-A)B. BRAUN MEDICAL INDUSTRIES SDN. BHD.Compare →
MAL20014354AEZISOTONE KOCHSALZ-LOSUNG 0.9% BRAUN IN 100ML PLASTIC CONTAINER9GM/1000MLPrescription (MAL-A)B. BRAUN MEDICAL INDUSTRIES SDN. BHD.Compare →
MAL19991924AEZISOTONIC SODIUM CHLORIDE SOLN IN 500ML PLASTIC CONTAINER0.9GM/1000MLPrescription (MAL-A)B. BRAUN MEDICAL INDUSTRIES SDN. BHD.Compare →

Generic Bioequivalence & Drug Substitution in Malaysia

Generic medications registered under NPRA contain the identical active pharmaceutical ingredient (API) in identical dosage strength and route of administration as the originator brand. NPRA requires rigorous bioequivalence (BE) studies demonstrating that generic drugs deliver the exact therapeutic effect. Always confirm with your doctor or community pharmacist before switching between prescription brands.